I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat
about
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemiaBone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategiesα-Linolenic Acid, A Nutraceutical with Pleiotropic Properties That Targets Endogenous Neuroprotective Pathways to Protect against Organophosphate Nerve Agent-Induced NeuropathologyNeuroprotective therapies in glaucoma: II. Genetic nanotechnology toolsMesenchymal stem cells for the treatment of neurodegenerative and psychiatric disordersIschemic stroke and repair: current trends in research and tissue engineering treatmentsThe multi-differentiation potential of peripheral blood mononuclear cellsMesenchymal stem cells migration homing and trackingDerivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured ratStem cells in human neurodegenerative disorders--time for clinical translation?Adult Stem Cell Therapy for Stroke: Challenges and ProgressAlpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic?Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemiaCurrent status of cell therapies in stroke.BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury.The effects of voluntary, involuntary, and forced exercises on brain-derived neurotrophic factor and motor function recovery: a rat brain ischemia model.Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery7,8-dihydroxyflavone, a small-molecule tropomyosin-related kinase B (TrkB) agonist, attenuates cerebral ischemia and reperfusion injury in rats.Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brainsComparative study among three different methods of bone marrow mesenchymal stem cell transplantation following cerebral infarction in rats.Effects of brain-derived neurotrophic factor on local inflammation in experimental stroke of ratPhenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cellsLocalized delivery of brain-derived neurotrophic factor-expressing mesenchymal stem cells enhances functional recovery following cervical spinal cord injury.Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke.Growth factors in ischemic stroke.Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats.Human mesenchymal stem cells - current trends and future prospectiveImproving the Post-Stroke Therapeutic Potency of Mesenchymal Multipotent Stromal Cells by Cocultivation With Cortical Neurons: The Role of Crosstalk Between CellsAchieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?Immune effects of mesenchymal stromal cells in experimental stroke.Fantasies about stem cell therapy in chronic ischemic stroke patientsNeurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells.New strategies for repairing the injured spinal cord: the role of stem cells.The Effect of CXCR4 Overexpression on Mesenchymal Stem Cell Transplantation in Ischemic Stroke.The Effects of Progesterone on Glial Cell Line-derived Neurotrophic Factor Secretion from C6 Glioma Cells.Systemic delivery of umbilical cord blood cells for stroke therapy: a review.Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan
P2860
Q24569823-845C4996-145D-4F06-863F-D997669A4F5CQ26740083-72CA4F0A-DB55-45EB-8DE5-68F0CE090C15Q26777019-A3827A77-95B2-40D5-9A86-7AB5CA4E0168Q26777286-1D46ACEE-2D1B-4820-8F81-6E8C79C741CEQ26801575-2B60DE9F-D24F-4AFC-AB36-6840C74CD861Q26851602-06AA512D-FC76-4093-B718-DFF0736C2898Q26852323-82817CBD-5F36-43CA-A868-1A01A9638EAEQ27003059-17EBF181-D834-4782-8A16-D2E87D37E35EQ27324122-0CFD0553-DC16-4BCC-816C-A97D9BF8B268Q27687068-75B61CB5-5104-4BA7-996D-75A6DAB67A52Q28066235-1535E08A-DDDA-47B6-A545-AECECA28CCBEQ28085176-B83A393A-C326-4C45-87CB-F8683BC8608EQ29620590-DD5026B0-6EA8-49E3-9F79-C8A4AE2A37C5Q33322707-F4E94C97-2F5F-4EC0-8651-E93E91E621BBQ33614825-B1143B9D-3F69-43BD-AC7F-FBC0DB0402A7Q33672421-99966130-E27C-45D6-87F5-3A1D8D4CFD2FQ33828865-141EC331-8E18-418F-B84F-BFE723733E3CQ34062490-72016F94-58C2-4716-8BF4-0178FC86FAC7Q34349428-91CECD2C-1F65-4240-9B16-F0DF53461C31Q34371932-54C79274-7838-432B-8BEB-9507119CD097Q34596733-E856BD38-FF93-4BAA-A520-B91702416D13Q34604523-A9F7CB74-F4E9-47A7-A849-47D7A36EF5BCQ34746626-2A34257F-2036-4613-A1D2-CD8284DEC140Q34768188-702B5B72-D65D-46FF-BCC0-4D1833C675B9Q34983856-F086A1F8-D5DE-409C-9D55-A971C38F3D5FQ35007847-2A08DEA9-E074-4E63-8C00-4A38C89E24C1Q35171618-C8569B69-6128-46B3-8D31-8B577E6FF4FFQ35216143-73892128-8786-4205-840D-E36DF1D842A0Q35396013-861AF74A-1203-46C8-8148-E1A54D544D8AQ35548329-A7862454-70FA-4289-8E50-568968B3BA40Q35687572-8A595668-8364-4938-BD6E-811A1A9F554BQ36111849-37FCD98B-F2FB-43FA-A452-7DDCF68323ADQ36170342-F729BBDD-66EB-42B5-A258-16E8144C10F3Q36482236-CAAEE681-6F2A-4809-B8D4-E50FCB7B9FCCQ36519737-E2308256-0563-43FA-930A-BEC03A53C764Q36523362-9B796FEF-3445-4A7F-ACA3-5CAD9F22D890Q36523465-22E3C0D6-E9C5-436B-8503-9DE0137D6D08Q36652633-ECECFE88-2BDB-4E4A-8D1E-EB62661B65C0Q36715654-C8367728-067D-43BC-8405-4AE2FCE9BA8DQ36775197-026A2493-5FA5-4758-AC10-F212D2014B35
P2860
I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
I.V. infusion of brain-derived ...... al ischemia model in adult rat
@en
I.V. infusion of brain-derived ...... l ischemia model in adult rat.
@nl
type
label
I.V. infusion of brain-derived ...... al ischemia model in adult rat
@en
I.V. infusion of brain-derived ...... l ischemia model in adult rat.
@nl
prefLabel
I.V. infusion of brain-derived ...... al ischemia model in adult rat
@en
I.V. infusion of brain-derived ...... l ischemia model in adult rat.
@nl
P2093
P2860
P1433
P1476
I.V. infusion of brain-derived ...... al ischemia model in adult rat
@en
P2093
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2005.06.062
P407
P50
P577
2005-10-17T00:00:00Z